Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)
Clinical trial NCT01523821 · COMPLETED
Trial details
- NCT number
- NCT01523821
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-11
- Primary completion
- 2017-01-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.